...
首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Upgrade of Single Chamber Pacemakers with Transvenous Leads to Dual Chamber Pacemakers in Pediatric and Young Adult Patients.
【24h】

Upgrade of Single Chamber Pacemakers with Transvenous Leads to Dual Chamber Pacemakers in Pediatric and Young Adult Patients.

机译:将带静脉导管的单腔起搏器升级为小儿和成年患者的双腔起搏器。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

SILVETTI, M.S., et al.: Upgrade of Single Chamber Pacemakers with Transvenous Leads to Dual Chamber Pacemakers in Pediatric and Young Adult Patients. Children with single chamber pacemakers, in adolescence and young adulthood, may be upgraded to dual chamber systems, but there are no published data about indications, timing, and complications. Upgrading was attempted in 18 patients with transvenous pacing leads. A retrospective analysis of all collected data was performed. At initial pacemaker implantation (mean +/- SD, 9.3 +/- 4.1 years), the pacing mode was VVIR (n = 13 patients) and AAI/AAIR (n = 5 patients). After 72 +/- 41 months of follow-up, at the age of 15.5 +/- 5.2 years, upgrade was undertaken because of the patient's age at elective generator replacement (n = 3 patients), ventricular dysfunction (n = 7), syncope/presyncope (n = 3) in patients with VVIR pacing, atrioventricular block (n = 2), and/or drug refractory supraventricular tachyarrhythmias (n = 4) in patients with atrial pacing. In comparison with single chamber pacemaker implantations, the average procedural time and the average fluoroscopy time were not significantly longer. All suitable preexisting leads were incorporated in the new pacing system. Leads were inserted via the ipsilateral subclavian vein in 16 patients. Venous occlusion was found in two patients: in the first the procedure was not performed; in the second, the contralateral vein was used and the old lead was abandoned. There were no procedural complications. During a follow-up of 14 +/- 11 months, ventricular dysfunction worsened in five of seven patients; other patients benefitted symptomatically. In conclusion, pacemaker upgrade is technically challenging but feasible and safe and may be beneficial for some patients. (PACE 2004; 27:1094-1098)
机译:美国马萨诸塞州锡尔维蒂(SILVETTI)等人:小儿和年轻成年患者将带静脉导管的单腔起搏器升级为双腔起搏器。具有单腔起搏器的儿童,在青春期和成年期可以升级为双腔系统,但是尚无有关适应症,​​时机和并发症的公开数据。尝试对18例经静脉起搏导线的患者进行升级。对所有收集的数据进行回顾性分析。起搏器植入初期(平均+/- SD,9.3 +/- 4.1年),起搏模式为VVIR(n = 13例)和AAI / AAIR(n = 5例)。随访72 +/- 41个月后,在15.5 +/- 5.2岁时进行了升级,原因是患者在选择更换发电机时的年龄(n = 3位患者),心室功能障碍(n = 7), VVIR起搏患者的晕厥/晕厥前发作(n = 3),房起搏患者的房室传导阻滞(n = 2)和/或药物难治性室上性快速性心律失常(n = 4)。与单腔起搏器植入相比,平均手术时间和平均透视时间没有明显更长。所有合适的预先存在的导线均已纳入新的起搏系统中。通过同侧锁骨下静脉将导线插入16例患者中。在两名患者中发现了静脉阻塞:第一例未进行手术;第二例未进行手术。在第二种方法中,使用了对侧静脉并且放弃了旧的导线。没有手术并发症。在14 +/- 11个月的随访期间,七名患者中有五名的心室功能障碍加重。其他患者在症状上受益。总之,起搏器升级在技术上具有挑战性,但可行且安全,对某些患者可能有益。 (PACE 2004; 27:1094-1098)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号